Identification and localization of a neuron-specific isoform of TAF1 in rat brain: Implications for neuropathology of DYT3 dystonia

Neuroscience

Volumn 189, Issue , 2011, Pages 100-107

  Sako, W ^a,b   Morigaki, R ^a,b   Kaji, R ^a,b   Tooyama, I ^c   Okita, S ^b   Kitazato, K ^b   Nagahiro, S ^a,b   Graybiel, A M ^d   Goto, S ^a,b  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

DYT3 dystonia; Neurodegeneration; Striosome; TAF1; Transcription dysregulation syndrome

Indexed keywords

NEURON SPECIFIC TATA BINDING PROTEIN ASSOCIATED FACTOR 1; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL NUCLEUS; CELL SPECIFICITY; CONTROLLED STUDY; CORPUS STRIATUM; DYSTONIA; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RAT; X CHROMOSOME LINKED DISORDER; X LINKED DYSTONIA PARKINSONISM;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CORPUS STRIATUM; DYSTONIA; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSCRIPTION FACTOR TFIID;

EID: 79960914214     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.05.031     Document Type: Article

References (35)

1. Albin R.L., Young A.B., Penny J.B. The functional anatomy of disorders of the basal ganglia. Trends Neurosci18 1995, 63-64.
2. Bressman S.B., Raymond D., Fuchs T., Heiman G.A., Ozelius L., Saunders-Pullman R. Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol 2009, 8:441-446.
3. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000, 3:377-383.
4. Chen B.S., Hampsey M. Transcription activation: unveiling the essential nature of TFIID. Curr Biol 2002, 12:R620-R622.
5. Crittenden J.R., Cantuti-Castelvetri I., Saka E., Keller-McGandy C.E., Hernandez L.F., Kett L.R., Young A.B., Standaert D.G., Graybiel A.M. Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy. Proc Natl Acad Sci USA 2009, 106:2892-2896.
6. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990, 13:281-289.
7. Ferrante R.J., Kowall N.W., Beal M.F., Martin J.B., Bird E.D., Richardson E.P. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 1987, 46:12-27.
8. Freman R.N., Tjian R. Neurodegeneration: a glutamine-rich trail leads to transcription factors. Science 2002, 296:2149-2150.
9. Goodchild R.E., Kim C.E., Dauer W.T. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005, 48:923-932.
10. Goto S., Lee L.V., Munoz E.L., Tooyama I., Tamiya G., Makino S., Ando S., Dantes M.B., Yamada K., Matsumoto S., Shimazu H., Kuratsu J.I., Hirano A., Kaji R. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol 2005, 58:7-17.
11. Goto S., Nagahiro S., Kaji R. Striosome-matrix pathology of dystonias: a new hypothesis for dystonia genesis. Dystonia: causes, symptoms and treatment 2010, 1-22. Nova Science Publishers, New York, NY. J. Kurstot, M. Forsstrom (Eds.).
12. Graybiel A.M. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008, 31:359-387.
13. Graybiel A.M., Canales J.J., Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 2000, 23:571-577.
14. Gubellini P., Pisani A., Centonze D., Bernardi G., Calabresi P. Metabotropic glutamate receptors and synaptic plasticity: implications for neurological diseases. Prog Neurobiol 2004, 74:271-300.
15. Haberhausen G., Schmitt I., Kohler A., Peters U., Rider S., Chelly J., Terwilliger J.D., Monaco A.P., Müller U. Assignment of the dystonia-parkinsonism syndrome locus, DYT3, to a small region within a 1.8-Mb YAC contig of Xq13.1. Am J Hum Genet 1995, 57:644-650.
16. Hedreen J.C., Folstein S.E. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 1995, 54:105-120.
17. Jakel R.J., Maragos W.F. Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends Neurosci 2000, 23:239-245.
18. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 1995, 18:527-535.
19. Kim T.H., et al. A high-resolution map of active promoters in the human genome. Nature 2005, 436:876-880.
20. Langley K.C., Bergson C., Greengard P., Ouimet C.C. Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen. Neuroscience 1997, 78:977-983.
21. Lee L.V., Maranon E., Demaisip C., Peralta O., Borres-Icasiano R., Arancillo J., Rivera C., Munoz E., Tan K., Reyes M.T. The natural history of sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Parkinsonism Relat Disord 2002, 9:29-38.
22. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
23. Makino S., Kaji R., Ando S., Tomizawa M., Yasuno Y., Goto S., Matsumoto S., Tabuena D., Maranon E., Dantes M., Lee L.V., Ogasawara K., Akatsu H., Nishimura M., Tamiya G. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet 2007, 80:393-406.
24. Matangkasombut O., Auty R., Buratowski S. Structure and function of the TFIID complex. Adv Protein Chem 2004, 67:67-69.
25. Müller U. The monogenic primary dystonias. Brain 2009, 132:2005-2025.
26. Nolte D., Niemann S., Müller U. Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism. Proc Natl Acad Sci U S A 2003, 100:10347-10352.
27. Paxinos G., Watson C. The rat brain in stereotactic coordinates 1986, Academic Press, San Diego. 2nd ed.
28. Pisani A., Bernardi G., Ding J., Surmeier J. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 2007, 30:545-553.
29. Sako W., Morigaki R., Nagahiro S., Kaji R., Goto S. Olfactory type G-protein α subunit (Gαolf) in striosome-matrix dopamine systems in adult mice. Neuroscience 2010, 170:497-502.
30. Sato K., Sumi-Ichinose C., Kaji R., Ikemoto K., Nomura T., Nagatsu I., Ichinose H., Ito M., Sako W., Nagahiro S., Graybiel A.M., Goto S. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A 2008, 105:12551-12556.
31. Tippett L.J., Waldvogel H.J., Thomas S.J., Hogg V.M., van Roon-Mom W., Synek B.J., Graybiel A.M., Faull L.M. Striosomes and mood dysfunction in Huntington's disease. Brain 2006, 130:206-221.
32. Trorrier Y., Devys D., Imbert G., Saudou F., An I., Lutz Y., Weber C., Agid Y., Hirsch E.C., Mandel J.L. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 1995, 10:104-110.
33. Vermeulen W., et al. Three unusual repair deficiencies associated with transcription factor BTF2 (TFIIH): evidence for the existence of a transcription syndrome. Cold Spring Harb Symp Quant Biol 1994, 59:317-329.
34. Wassarman D.A., Aoyagi N., Pile L.A., Schlag E.M. TAF250 is required for multiple developmental events in Drosophila. Proc Natl Acad Sci U S A 2000, 97:1154-1159.
35. Wassarman D.A., Sauer F. TAFII250: a transcription toolbox. J Cell Sci 2001, 114:2895-2902.